Literature DB >> 11576875

Predicting progression in IgA nephropathy.

L P Bartosik1, G Lajoie, L Sugar, D C Cattran.   

Abstract

Immunoglobulin A (IgA) nephropathy is one of the most common primary types of glomerulonephritis to progress to end-stage renal disease. Its variable and often long natural history makes it difficult to predict outcome. We investigated the association of the rate of renal function decline based on the slope of creatinine clearance over time with demographic, clinical, laboratory, and histological data from 298 patients with biopsy-proven IgA nephropathy with a mean follow-up of 70 months. Using univariate analysis, urinary protein excretion at baseline and Lee pathological grading, as well as mean arterial pressure (MAP) and urinary protein excretion during follow-up, were associated with the rate of deterioration in renal function. Of these, only MAP and urinary protein excretion during follow-up were identified as independent factors by multiple linear regression analysis. The combination of best accuracy of prediction and shortest observation time using these two parameters was reached between the second and third years of follow-up. A semiquantitative method of estimating the rate of progression by using these factors was developed. These results indicate that MAP and severity of proteinuria over time are the most important prognostic indicators of IgA nephropathy. The potential relevance of the algorithm in patient management is shown.

Entities:  

Mesh:

Year:  2001        PMID: 11576875     DOI: 10.1053/ajkd.2001.27689

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  99 in total

1.  Long-term results of a randomized controlled trial in childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Mari Saito; Mayumi Sako; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

Review 2.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

3.  Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Ritsuko Katafuchi; Kosuke Masutani; Akihiro Tsuchimoto; Hideko Noguchi; Hideki Hirakata; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

4.  Progression of IgA nephropathy under current therapy regimen in a Chinese population.

Authors:  Xiangling Li; Youxia Liu; Jicheng Lv; Sufang Shi; Lijun Liu; Yuqing Chen; Hong Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 8.237

5.  Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy.

Authors:  Dan Wu; Xueqian Li; Xingfeng Yao; Nan Zhang; Lei Lei; Hejia Zhang; Mengmeng Tang; Jie Ni; Chen Ling; Zhi Chen; Xiangmei Chen; Xiaorong Liu
Journal:  Clin Exp Nephrol       Date:  2021-02-23       Impact factor: 2.801

6.  Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kandai Nozu; Kazumoto Iijima; Yuko Shima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2014-12-10       Impact factor: 3.714

7.  Histopathologic features aid in predicting risk for progression of IgA nephropathy.

Authors:  Michael Walsh; Aylin Sar; Diane Lee; Serdar Yilmaz; Hallgrimur Benediktsson; Braden Manns; Brenda Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

8.  alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.

Authors:  Mara Ferrandi; Daniele Cusi; Isabella Molinari; Lucia Del Vecchio; Cristina Barlassina; Maria Pia Rastaldi; Francesco Paolo Schena; Fabio Macciardi; Carmelita Marcantoni; Dario Roccatello; Luanne L Peters; Silvia Armelloni; Li Min; Laura Giardino; Deborah Mattinzoli; Claudio Camisasca; Fiorentina Palazzo; Paolo Manunta; Patrizia Ferrari; Giuseppe Bianchi
Journal:  J Mol Med (Berl)       Date:  2009-10-17       Impact factor: 4.599

9.  Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study.

Authors:  Koichi Nakanishi; Kazumoto Iijima; Kenji Ishikura; Hiroshi Hataya; Midori Awazu; Mayumi Sako; Masataka Honda; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2008-09-30       Impact factor: 3.714

10.  Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading.

Authors:  Kazutaka Nakayama; Isao Ohsawa; Atsuko Maeda-Ohtani; Maki Murakoshi; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.